Could an infusion every 8 weeks replace daily HIV pills?

NCT ID NCT07215468

Ongoing Disease control Sponsor: TaiMed Biologics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests whether a combination of two antibodies (TMB-365 and TMB-380) given as an infusion every 8 weeks can keep HIV under control in people who are already suppressed on daily oral medication. About 88 adults with HIV will either switch to the antibody infusions or stay on their daily pills for 48 weeks. The goal is to see if the antibody combination works as well as daily pills to maintain viral suppression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV-1-INFECTION

Contacts and locations

Locations

CAN Community Health Fort Lauderdale

Fort Lauderdale, Florida, 33316, United States
CAN Community Health Las Vegas

Las Vegas, Nevada, 89104, United States
CAN Community Health Miami Gardens

Miami Gardens, Florida, 33055, United States
CAN Community Health Sarasota

Sarasota, Florida, 34237, United States
Midland Medical

Oakland Park, Florida, 33334, United States
Midway Immunology and Research Center (MIRC)

Ft. Pierce, Florida, 34982, United States
Orlando Immunology Center

Orlando, Florida, 32803, United States
Quest Clinical Research

San Francisco, California, 94115, United States
The Crofoot Research Center, Inc.

Houston, Texas, 77098, United States
The Rockefeller University

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.